283 related articles for article (PubMed ID: 29290596)
1. Management of older adults with myelodysplastic syndromes (MDS).
Luskin MR; Abel GA
J Geriatr Oncol; 2018 Jul; 9(4):302-307. PubMed ID: 29290596
[TBL] [Abstract][Full Text] [Related]
2. Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes.
Abel GA; Buckstein R
Am Soc Clin Oncol Educ Book; 2016; 35():e337-44. PubMed ID: 27249740
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Cell Transplantation for Myelodysplastic Syndromes.
Bhatt VR; Steensma DP
J Oncol Pract; 2016 Sep; 12(9):786-92. PubMed ID: 27621329
[TBL] [Abstract][Full Text] [Related]
4. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
Aul C; Giagounidis A; Germing U; Ganser A
Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
[TBL] [Abstract][Full Text] [Related]
5. Palliative and End-of-Life Care in Myelodysplastic Syndromes.
Nickolich M; El-Jawahri A; LeBlanc TW
Curr Hematol Malig Rep; 2016 Dec; 11(6):434-440. PubMed ID: 27704467
[TBL] [Abstract][Full Text] [Related]
6. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Slade M; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Romee R
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1736-1743. PubMed ID: 28688919
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
Yucel OK; Saliba RM; Rondon G; Ahmed S; Alousi A; Bashir Q; Ciurea SO; Popat U; Khouri I; Marin D; Rezvani K; Kebriaei P; Shpall EJ; Champlin RE; Oran B
Cancer; 2017 Jul; 123(14):2661-2670. PubMed ID: 28324640
[TBL] [Abstract][Full Text] [Related]
8. Personalized treatment strategies for elderly patients with myelodysplastic syndromes.
Castelli R; Bergamaschini L; Schiavon R; Lambertenghi-Deliliers G
Expert Rev Hematol; 2017 Dec; 10(12):1077-1086. PubMed ID: 29069953
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
Garcia-Manero G
Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly.
Klepin HD
Clin Geriatr Med; 2016 Feb; 32(1):155-73. PubMed ID: 26614866
[TBL] [Abstract][Full Text] [Related]
11. The impact of anaemia, transfusion dependency, comorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes.
Castelli R; Schiavon R; Deliliers GL
Med Oncol; 2018 Feb; 35(3):33. PubMed ID: 29417235
[TBL] [Abstract][Full Text] [Related]
12. Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).
Atallah E; Bylow K; Troy J; Saber W
Curr Hematol Malig Rep; 2014 Mar; 9(1):57-65. PubMed ID: 24398726
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndromes in the United States: an update for clinicians.
Troy JD; Atallah E; Geyer JT; Saber W
Ann Med; 2014 Aug; 46(5):283-9. PubMed ID: 24716735
[TBL] [Abstract][Full Text] [Related]
14. A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.
Hu KX; Sun QY; Guo M; Qiao JX; Yu CL; Qiao JH; Dong Z; Sun WJ; Zuo HL; Huang YJ; Cai B; Ai HS
Stem Cells Transl Med; 2016 Apr; 5(4):524-9. PubMed ID: 26838271
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndrome.
Cutler C
Hematology Am Soc Hematol Educ Program; 2010; 2010():325-9. PubMed ID: 21239814
[TBL] [Abstract][Full Text] [Related]
16. Integrating patient-centered factors in the risk assessment of MDS.
Buckstein RJ
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):373-380. PubMed ID: 31808887
[TBL] [Abstract][Full Text] [Related]
17. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: a multicenter retrospective study.
Okuyama N; Sperr WR; Kadar K; Bakker S; Szombath G; Handa H; Tamura H; Kondo A; Valent P; Várkonyi J; van de Loosdrecht A; Ogata K
Leuk Res; 2013 Aug; 37(8):862-7. PubMed ID: 23507195
[TBL] [Abstract][Full Text] [Related]
20. Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and Medicaid Services.
Giralt SA; Horowitz M; Weisdorf D; Cutler C
J Clin Oncol; 2011 Feb; 29(5):566-72. PubMed ID: 21220586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
